Emil Frei
Impact in
- Oncology top 0.1%
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 99
- Cancer Treatment and Pharmacology 44
- Neutropenia and Cancer Infections 22
-
- Cancer therapeutics and mechanisms 23
- Co-authors
- Emil J. Freireich (30 shared papers)George P. Canellos (5 shared papers)James K. Luce (11 shared papers)D H Ho (7 shared papers)Paul P. Carbone (10 shared papers)JACQUELINE WHANG (6 shared papers)Gerald P. Bodey (10 shared papers)A. Rosowsky (8 shared papers)
- Journals
- Cancer (33 papers)New England Journal of Medicine (14 papers)Journal of Clinical Oncology (13 papers)Blood (11 papers)Clinical Pharmacology & Therapeutics (9 papers)
- Partner nations
- United StatesUnited KingdomMalaysia
In The Last Decade
Emil Frei
265 papers receiving 14.1k citations
Emil Frei's Hit Papers
Peers
Comparison fields: 5 of 162
- Oncology 6.2k
- Hematology 2.3k
- Genetics 1.3k
- Cancer Research 1.7k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Emil Frei
This map shows the geographic impact of Emil Frei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Frei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Frei more than expected).
Fields of papers citing papers by Emil Frei
This network shows the impact of papers produced by Emil Frei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Frei. The network helps show where Emil Frei may publish in the future.
Co-authors
The 25 scholars most cited alongside Emil Frei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer Hit paper breakdown → | 2003 | 925 |
| 2 | A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer Hit paper breakdown → | 1990 | 880 |
| 3 | Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide Hit paper breakdown → | 1960 | 864 |
| 4 | Dose: A critical factor in cancer chemotherapy Hit paper breakdown → | 1980 | 654 |
| 5 | Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression Hit paper breakdown → | 1988 | 538 |
| 6 | 1998 | 468 | |
| 7 | A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Hit paper breakdown → | 1978 | 414 |
| 8 | 1975 | 266 | |
| 9 | 1988 | 251 | |
| 10 | 1990 | 246 | |
| 11 | 1971 | 242 | |
| 12 | 1963 | 236 | |
| 13 | 1965 | 209 | |
| 14 | 1973 | 193 | |
| 15 | 1988 | 190 | |
| 16 | 1971 | 186 | |
| 17 | Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). | 1969 | 177 |
| 18 | Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. | 1974 | 168 |
| 19 | 1963 | 167 | |
| 20 | 1972 | 167 |
About Emil Frei
Emil Frei is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Public Health, Environmental and Occupational Health, having authored 272 papers that have together received 15.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (44 papers), Acute Lymphoblastic Leukemia research (36 papers), Acute Myeloid Leukemia Research (30 papers), Lung Cancer Treatments and Mutations (29 papers), Lymphoma Diagnosis and Treatment (24 papers), Cancer therapeutics and mechanisms (23 papers), Neutropenia and Cancer Infections (22 papers) and Chronic Lymphocytic Leukemia Research (20 papers). The work is most often cited by research in Oncology (6.2k citations), Hematology (2.3k citations), Genetics (1.3k citations), Cancer Research (1.7k citations) and Pathology and Forensic Medicine (1.7k citations). Emil Frei has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Emil J. Freireich, George P. Canellos, James K. Luce, D H Ho, Paul P. Carbone, JACQUELINE WHANG, Gerald P. Bodey, A. Rosowsky, Robert W. Carey and Lowell E. Schnipper. Their work appears in journals such as Cancer, New England Journal of Medicine, Journal of Clinical Oncology, Blood and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.